Company profile

Immunitor company profile

Since 2000, Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, cancer; and atherosclerosis/obesity. Immunitor Inc. is the global holding corporation for Immunitor product and manufacturing rights and assets. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunitor products are registered in several Asian and African countries. Immunitor CEO is Dr. Aldar S. Bourinbaiar, the manufacturing plant is run by Mr. Vichai Jirathitikal. These two individuals are..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Founded
2000-01-01

Headquarters

Headquarters
Batabo, Aleppo, Syria
Country code
SY
Continent
Asia

Capital profile

Funding and company signals

Founders
2
Articles
1

Founders and investors

Founders

Aldar BourinbaiarVichai Jirathitikal

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.